ArborMetrix

By A2Hub Editorial. Published 2026-04-22. Last updated: 2026-04-22.

At a glance

• Founded: 2011
• Founders: Justin Dimick (U-M surgeon and health services researcher), Brett Furst, John Birkmeyer (then at U-M, later Dartmouth), and the U-M Center for Healthcare Outcomes & Policy lineage
• HQ: Liberty Street, downtown Ann Arbor
• Employees: Roughly 100, based on most recent public reporting
• Funding raised: Approximately $33M total, across multiple rounds with Beringea, Arboretum Ventures, Baird Capital and others
• Status: Private, growth-stage. Backed by healthcare-focused growth investors.
• Website: arbormetrix.com

The pitch in one line

ArborMetrix turns clinical registries from compliance paperwork into measurable patient outcomes. The company runs the data infrastructure behind some of the largest US specialty society and government quality registries, and it does it from a downtown Ann Arbor office.

Founding story: outcomes research with the safety taken off

ArborMetrix is one of the cleanest examples of how University of Michigan health services research becomes a software company. The University of Michigan Center for Healthcare Outcomes & Policy (CHOP) and the Dartmouth Atlas program both spent the 2000s establishing a hard truth that hospital administrators did not love: outcomes for the same procedure vary wildly between hospitals, and most of that variation is not explained by patient mix. If you can measure it, you can fix it. If you cannot measure it, every hospital tells itself it is above average.

Justin Dimick, who chairs U-M's Department of Surgery, spent his early career building the statistical methods to measure surgical outcomes at the hospital and surgeon level. John Birkmeyer ran the Michigan Surgical Quality Collaborative for years before moving to Dartmouth. The intellectual lineage is the Dartmouth Atlas plus the Michigan collaborative model, applied to a software platform that any specialty society could deploy.

ArborMetrix incorporated in 2011 as the commercialization of that lineage. The thesis: clinical registries collect mountains of structured outcome data, but the technology stack is usually a patchwork of CSV uploads, hospital portals, and Excel reports that cannot answer real questions in real time. Replace the patchwork with one platform, and registries graduate from quality improvement projects into the source of truth for value-based care contracts.

What they build

ArborMetrix runs the data plumbing for clinical specialty registries. The platform ingests structured and unstructured data from hospitals, EHRs, claims sources, and patient-reported outcome tools, normalizes it, risk-adjusts the comparisons, and surfaces benchmarks back to participating clinicians and administrators.

Three product lines anchor the platform.

Registry platform. Multi-site clinical data capture, risk-adjustment, dashboards, benchmarking, and regulatory reporting for specialty societies and quality collaboratives. Customers include Qualified Clinical Data Registries (QCDRs) recognized by CMS for the Merit-based Incentive Payment System.

AMx Engage (patient-reported outcomes). Captures patient-reported outcomes longitudinally, integrates them into the registry view, and lets clinicians compare functional and quality-of-life outcomes alongside the clinical record. Launched relatively recently and represents the company's bet that the next decade of value-based care depends on measuring what the patient actually feels, not only what the surgeon documents.

Real-world evidence services. Increasingly important for life sciences and pharma customers who need post-market evidence for FDA, payers, and label expansions.

The company's customer mix sits at the intersection of clinical specialty societies, large integrated delivery networks, and life sciences companies that want post-market real-world data. That breadth is hard to assemble; it is the reason ArborMetrix has the contract footprint it does despite operating from a building most Ann Arbor residents would not associate with high-end clinical software.

Funding history

ArborMetrix has raised on the order of $33M total across institutional rounds. Lead investors have included Beringea (the same growth-stage fund that backs Genomenon), Arboretum Ventures (the regional healthcare specialist), and Baird Capital. The company has not pursued the kind of breakneck growth-equity round that would force a sale or a public listing. The capital strategy reads as deliberate: enough fuel to scale registry partnerships, not so much that the math of capital efficiency stops working.

That posture is consistent with how Ann Arbor healthcare IT companies have historically scaled. The Truven Health Analytics arc (Ann Arbor HQ, sold to IBM Watson Health for $2.6B in 2016, later carved out into Merative) is the local template. Build a defensible data asset, sell access to operators and pharma, do not chase the consumer-internet growth curve.

Ann Arbor footprint

ArborMetrix's headquarters sits on Liberty Street in the heart of downtown Ann Arbor, a few blocks from the Liberty Square building that houses the Cisco Duo team and within walking distance of the Censys office on Main Street. The location matters: ArborMetrix is one of the downtown employers that anchors the after-hours density of the Liberty / Main / Fourth Ave corridor.

The company hires both clinical informaticists (epidemiology, biostatistics, public health backgrounds) and standard product engineering (web, data engineering, cloud infrastructure). Most senior clinical roles overlap with U-M Medical School and School of Public Health alumni networks. The recruiting story is straightforward: you can work on healthcare data that actually shapes how care is delivered, you can do it from a small downtown office, and you can keep your kids in Ann Arbor Public Schools.

Leadership and people

Justin Dimick remains a public face of the company, although his day job is chairing U-M Surgery. The operating leadership has rotated through a series of healthcare-IT executives with experience at Truven, Optum, and IBM Watson Health, which is the standard executive bench for an Ann Arbor health analytics firm. Brett Furst, an early operating partner, has been associated with the company since the founding period. ArborMetrix has not produced the kind of charismatic founder-CEO public profile that Workit Health or HistoSonics have, but that is in keeping with the registry-software business: the buyers are clinical society executives and CMOs, not consumers.

Why it matters

Three reasons ArborMetrix matters for the Ann Arbor story.

First, it is one of the cleanest examples of U-M health services research becoming a durable software company. The Dartmouth Atlas / Michigan Surgical Quality Collaborative lineage is academic infrastructure that most universities never commercialize. ArborMetrix did. That maps directly onto the University of Michigan tech startups story.

Second, it sits inside the broader Ann Arbor health analytics cluster: Truven Health Analytics (now Merative), Genomenon, Strata Oncology, and ArborMetrix all share data scientists, software engineers, and customers across pharma and provider networks. That is the kind of cluster effect that makes a city defensible against coastal competition for healthcare data talent.

Third, ArborMetrix is a profitability-first counterexample to the AI-hype cycle. Real-world evidence, registries, and risk-adjusted outcomes are not glamorous. They are the connective tissue of value-based care. Companies that own that tissue tend to outlast the cycles.

Related

• Strata Oncology is the precision oncology network that runs a complementary real-world data play in cancer.
• Genomenon is the U-M spinout that built the Mastermind genomic search engine; it overlaps with ArborMetrix on real-world evidence customers in life sciences.
• Ripple Science is the clinical trial recruitment SaaS that shares the Ann Arbor clinical-software talent pool.
• The biotech category hub lists every Ann Arbor biotech firm we cover.
• The companies directory is the master index across every category.

FAQ

Where is ArborMetrix headquartered? ArborMetrix is headquartered on Liberty Street in downtown Ann Arbor, Michigan, a few blocks from the Cisco Duo and Censys offices.

Who founded ArborMetrix? The company was founded in 2011 as a commercialization of health services research from the University of Michigan Center for Healthcare Outcomes & Policy and the Dartmouth Atlas program. Justin Dimick (U-M Surgery), Brett Furst, and John Birkmeyer were core figures in the founding period.

What does ArborMetrix do? ArborMetrix runs the data infrastructure behind clinical specialty registries. The platform ingests, normalizes, and risk-adjusts outcome data from hospitals and EHRs, and it surfaces benchmarks and quality reporting back to clinicians, administrators, payers, and life sciences partners.

How much funding has ArborMetrix raised? The company has raised roughly $33M in total funding across institutional rounds led by Beringea, Arboretum Ventures, Baird Capital, and others, per recent reporting.

Is ArborMetrix related to Arbor Networks or Arbor Research Collaborative for Health? No. The "Arbor" prefix is shared by many Ann Arbor companies (it is short for Ann Arbor and a nod to the city's tree). ArborMetrix is a healthcare data analytics company; Arbor Networks is the DDoS pioneer now inside NETSCOUT; Arbor Research Collaborative for Health is a separate nonprofit research organization in Ann Arbor.

Who are ArborMetrix's customers? The customer base spans clinical specialty societies that operate Qualified Clinical Data Registries (QCDRs), large integrated delivery networks, government quality reporting programs, and life sciences companies that need post-market real-world evidence.